Maricruz Anaya-Ruiz

16PUBLICATIONS
23CO-AUTHORS
Molecular targetsCancer diagnosisGene and molecular therapyMolecular medicineCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 26, 2026
Botulinum Neurotoxin-A Inhibits Tumor Growth in a Triple-Negative Breast Cancer Preclinical Model.

|Jan 08, 2026
LAG-3 antagonists for cancer treatment: an updated patent review (2020-2025).

Martín Pérez-Santos, Gerardo Landeta, Maricruz Anaya-Ruiz

|Nov 03, 2025
[2018-2024 Cancer Trends in Pathology of a Hospital in Eastern Mexico].

Alejandro González-Zago, Fátima Angelina Fierro-Atondo, Nayeli Ramírez-Juárez

|Oct 06, 2023
Drug repurposing of mito-atovaquone for cancer treatment.

Nemesio Villa-Ruano, Maricruz Anaya-Ruiz, Luis Villafaña-Diaz

|Nov 18, 2022
Approaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents.

Martin Perez-Santos, Maricruz Anaya-Ruiz, Luis Villafaña-Diaz

|Feb 16, 2022
Drug repurposing of adapalene for melanoma treatment.

Maricruz Anaya-Ruiz, Martin Perez-Santos

Pageof 3

Frequent Collaborators

14 joint publications

Perez-Santos Martin

5 joint publications

Cindy Bandala

3 joint publications

Luis Villafaña-Diaz

2 joint publications

Irma Herrera-Camacho